BioAge Labs, Inc. (BIOA)
8.09
+0.03
(+0.37%)
USD |
NASDAQ |
Sep 21, 16:00
8.08
-0.01
(-0.12%)
After-Hours: 20:00
BioAge Labs EPS Diluted (TTM) : -2.387 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.387 |
| March 31, 2026 | -2.406 |
| December 31, 2025 | -2.243 |
| September 30, 2025 | -2.114 |
| June 30, 2025 | -2.236 |
| March 31, 2025 | -2.032 |
| December 31, 2024 | -2.052 |
| Date | Value |
|---|---|
| September 30, 2024 | -2.075 |
| June 30, 2024 | -1.818 |
| March 31, 2024 | -1.924 |
| December 31, 2023 | -1.868 |
| September 30, 2023 | -1.255 |
| June 30, 2023 | -0.8274 |
| March 31, 2023 | -0.3244 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Eli Lilly & Co. | 29.43 |
| Pfizer Inc. | 0.7552 |
| Oramed Pharmaceuticals, Inc. | 4.110 |
| Liquidia Corp. | 1.364 |
| Neumora Therapeutics, Inc. | -1.233 |